Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Clinical trial NCT07087912 · RECRUITING

Trial details

NCT number: NCT07087912
Sponsor: University of Sao Paulo General Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis (RA)Juvenile Idiopathic Arthritis (JIA)Systemic Lupus Erythematosus (SLE)Juvenile Systemic Lupus Erythematosus Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathies (IIMs)Axial Spondyloarthritis Psoriatic Arthritis (PsA)Granulomatosis With Polyangiitis Microscopic Polyangiitis Antiphospholipid Syndrome Takayasu Arteritis

Start date: 2026-03-16
Primary completion: 2027-12-30
Enrollment: 477

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.